PsA: T-Cell Blockade

Orencia Approved for Use in Psoriatic Arthritis

On July 6 the U.S. Food and Drug Administration (FDA) approved ORENCIA (abatacept) for the treatment of adults with active Psoriatic Arthritis (PsA).…
rheumnow.com

FDA Approves Orencia for Psoriatic Arthritis

FDA Approves Orencia for Psoriatic Arthritis
mdedge.com

FDA approves Orencia for PsA

The FDA has approved Orencia for the treatment of patients with active psoriatic arthritis. It is approved for both subcutaneous and intravenous injections, according to a company press release. “This approval underscores the efficacy of Orencia in adult patients with active psoriatic arthriti…
healio.com